Pathways leading to coronary revascularisation among patients with diabetes in Finland: a longitudinal register-based

Tuulikki Vehko1, Reijo Sund, Kristiina Manderbacka

  • 1Health and Social Services, Service Systems Research Unit, National Institute for Health and Welfare (THL), Helsinki, Finland. tuulikki.vehko@thl.fi

Insights

Diabetic patients with coronary heart disease (CHD) are less likely to receive timely revascularization during their initial hospital admission. This study highlights disparities in treatment pathways, emphasizing the need for improved management of diabetic CHD patients.

Area of Science:

  • Cardiology
  • Diabetology
  • Health Services Research

Background:

  • Chronic conditions like coronary heart disease (CHD) require systematic, long-term management.
  • Effective disease management presents challenges for healthcare systems.
  • This study investigates treatment pathways for coronary revascularization in patients with and without diabetes.

Purpose of the Study:

  • To compare treatment pathways leading to coronary revascularization in patients with and without diabetes.
  • To identify temporal trends in revascularization procedures.
  • To assess the occurrence of suboptimal treatment pathways, including multiple emergency hospitalizations.

Main Methods:

  • Retrospective, nationwide, register-based study in Finland (1998-2007).
  • Analysis of temporal trends in revascularization timing and pathway characteristics.
  • Logistic regression used to compare patient groups, adjusting for age, comorbidity, and region.

Main Results:

  • Revascularization during the first hospital admission increased significantly for all groups from 1998 to 2007.
  • Diabetic patients (both insulin-dependent and non-insulin dependent) were less likely to undergo revascularization during their first admission compared to non-diabetic patients.
  • In 2005-2007, odds ratios for first admission revascularization were significantly lower for diabetic men and women compared to non-diabetic men.

Conclusions:

  • Treatment practices evolved towards earlier revascularization, likely due to increased coronary angioplasty.
  • Diabetic patients undergoing revascularization experienced fewer procedures during initial hospitalization and more pre-operative emergency admissions.
  • Enhanced attention to referral pathways for diabetic CHD patients is crucial to prevent adverse cardiac events.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...